Estate Counselors’s Zosano Pharma Corporation ZSAN Stock Holding History

Estate Counselors’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-143	Closed	-$1K	–	206
2022 Q1	$1K	Hold	143	–	–	﹤0.01%	162
2021 Q4	$2K	Hold	143	–	–	﹤0.01%	165
2021 Q3	$3K	Hold	143	–	–	﹤0.01%	173
2021 Q2	$4K	Hold	143	–	–	﹤0.01%	166
2021 Q1	$6K	Buy	+143	New	+$5.99K	﹤0.01%	165

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Estate Counselors's ZSAN Position: Q2 2022 in Review

Estate Counselors sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 143 shares — an estimated $1K sold.

Estate Counselors first reported a position in ZSAN in Q1 2021 and held it in 5 quarters. The position peaked at $6K in Q1 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Estate Counselors reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Estate Counselors sold 143 Zosano Pharma Corporation shares in Q2 2022, an estimated $1K.
Estate Counselors first reported a position in Zosano Pharma Corporation in Q1 2021 and held it in 5 quarters.
Estate Counselors's Zosano Pharma Corporation position peaked at $6K in Q1 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Estate Counselors's 13F filing for Q2 2022, filed 3 Aug 2022.